Mesenchymal Stem Cell Therapy in Congenital and Acquired Corneal Opacities
R$ 0,00
Suprachoroidal MSC Cell Implantation in AMD
R$ 0,00
Suprachoroidal Adipose Tissue-Derived Mesenchymal Stem Cell Implantation in Patients with Dry-Type Age-Related Macular Degeneration and Stargardt's Macular Dystrophy: 6-Month Follow-Up Results of a Phase 2 Study
You may also like
Mesenchymal stem cell therapy in deficiency dry eye disease.
R$ 0,00
Tissue Regeneration in a Glaucoma Model
R$ 0,00
Diversified Treatment Options of Adult Stem Cells for Optical Neuropathies
R$ 0,00
Cell Therapy and Covid
R$ 0,00
Stem cells and Spike protein
R$ 0,00
The Gut-Eye Axis: Lessons Learned from Murine Models
R$ 0,00
Bone marrow stem cells in the treatment of macular degeneration.
R$ 0,00
Scientific Article: Ferroptosis and the Eyes
R$ 0,00
Pluripotent Stem Cell Therapy for Retinal Diseases
R$ 0,00
Circulating haematopoietic stem cells and long-term outcomes of COVID-19
R$ 0,00
When stem cells meet COVID-19
R$ 0,00
Long Covid Syndrome
R$ 0,00
Effects of homeopathic remedies on stem cells
R$ 0,00
Regenerative retinal therapy with stem cells
R$ 0,00
Stem Cells Therapy for COVID-19: A Systematic Review and Meta-Analysis
R$ 0,00